Lifecore Biomedical (LFCR) has provided an update.
Lifecore Biomedical, Inc. is on the brink of being delisted from the Nasdaq Global Select Market due to non-compliance with filing requirements for its quarterly reports. Despite receiving a notice of delinquency, the company’s stock continues to trade normally as they appeal the delisting decision and request more time to meet the necessary regulations. The outcome of their appeal and their compliance efforts remain uncertain, as the Nasdaq Hearings Panel has yet to decide on their fate.
For a thorough assessment of LFCR stock, go to TipRanks’ Stock Analysis page.
